An accomplished executive with a career spanning over 34 years in medical diagnostics, devices and digital health, Tim’s background includes extensive experience in raising capital as well as designing and implementing highly focused commercial/business development strategies within both large and small companies.

Tim is currently Chairman and CEO of TSTILL Enterprises LLC, and an Operating Partner with Revival Healthcare Capital, where he is involved in evaluating and managing compelling investment opportunities in medical technology.

Tim has been directly responsible for building the commercial viability at all of his previous companies – many of which have been successfully acquired. His most recent operating role was President and CEO of Sense Biodetection. Early in 2023, Sense Bio was merged with Sherlock Biosciences to create a leading point of care diagnostics company serving the consumer diagnostics market.

Prior to Sense Biodetection, Tim has been a CEO and Board member at numerous medical technology companies: Myoscience, MDx Health (Board member), Gold Standard Diagnostics (Executive Chairman), Global Kinetics, Xagenic and Accumetrics. Earlier in his career, Tim also held senior leadership roles at HemoSense, Cholestech, Boehringer Mannheim & Roche.

Tim has a master’s degree in business administration (Dean’s Scholar) from the University of Southern California, and a Bachelor of Science degree (Highest Honors) from the University of California at Davis.

EXPERTISE

Medical Diagnostics

Life Science Tools

Medical Devices

Digital Health

Commercial Strategies

EXPERIENCE

Sense Biodetection

President & CEO, Board Member

JLL Partners

Medical Diagnostics Industry Advisor

Myoscience

President & CEO, Board Member

Gold Standard Diagnostics

Executive Chairman

EDUCATION

University of Southern California

MBA, Marketing and Entrepreneurship

University of California at Davis

BS, Biological Sciences

Investment Team